Publicaciones en colaboración con investigadores/as de Queen Mary University of London (1)

2017

  1. Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)

    Diabetes, Obesity and Metabolism, Vol. 19, Núm. 7, pp. 1024-1031